Female Patients Less Likely to Receive Guideline-Directed HFrEF Therapies vs Males
A recent study found that use of optimal guideline-directed medical therapies after heart failure with reduced ejection fraction (HFrEF) diagnosis is low overall, but especially among female patients compared with male patients.
Source: ajmc.com